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Polymyxins 
1947 from Paenibacillus polymyxa subsp. colistinus 
1959: FDA approved the prodrug (colistimethate, CMS) for parenteral use 
Phe Leu 
Narrow spectrum against Gram-negatives 
Most Enterobacteriaceae: E. coli, Enterobacter spp. 
Klebsiella spp., Citrobacter spp., Salmonella spp., and 
Shigella spp. 
Nonfermenters: A. baumannii, P. aeruginosa, Steno. 
maltophilia 
Naturally resistant: Proteus spp., M. morganii, 
Providencia spp., S. marcescens, Ps. mallei, B. cepacia, 
Brucella, Legionella, Campylobacter, V. cholerae 











Ampicillin R R R R 
Amoxicillin-clav. S I/R R R 
Piperacillin-tazob. S I/R R R 
Cefoxitin S R R R 
Cephalotin S R R R 
Cefpodoxime S R R R 
Ceftriaxone S R R R 
Cefotaxime S R R R 
Ceftazidime S R R R 
Cefepime S S/R R R 
Aztreonam S R R R 
Imipenem S S R R 
Meropenem S S R R 
Gentamicin S S/R R R 
Tobramycin S S/R R R 
Amikacin S S R R 
Ciprofloxacin S R R R 
Doxycycline S R R R 
Trimethoprim/sulfa. S R R R 
Fosfomycin S S S/R R 
Tigecycline S S S/R R 






















Giacobbe DR et al., CMI, 2015 
X2 for trend, P<0.001 
Six Italian hospitals, Jan 2010 – June 2014 
Monomicrobial BSI due to KPC-K. pneumoniae 
Colistin-S (control) vs. Colistin-R (case) 
Acquired Resistance: “Chromosomal First” 
CATIONIC GROUPS 
Naturally R species express 
arnBCADTEF operon and/or eptB gene  
A large panel of genes and operons are involved in qualitative modification of LPS 
(Poirel L et al., Clinical Microbiol Review, April 2017) 
Colistin-S 
Colistin-R 
ICU-patient – Italy (Bologna) 
• KKBO-1: KPC-Kp Colistin-S in blood 
• Colistin aerosolized, 25 days 
• Colistin i.v., 14 days 
• 30 days later 
KKBO-4: KPC-Kp Colistin-R in blood 
• Identical strains (=PFGE and ST258)  
Also confirmed in vitro 
- KKBO-1 on agar plates with colistin [8 mg/L] 
- Colistin-R mutants with 7 x 10-7 frequency 
- 60% had insertion of IS5-like 
- No fitness cost (same authors; AAC, 2015) 
47 Col-R KPC-Kp (mostly ST258) 
12 had mutated mgrB 
More IS inserted  
in mgrB 
IS in the promoter  
of mgrB 
Stop codon mgrB 
Italy and Greece, 2010-2012 
66 Col-R KPC-KP 
Mostly, ST258 and ST512 
mgrB status: 
• 41%: WT 
• 27%: Insertion of IS5-like at nt 75 
• 8%: g109a (G37S) 
• 5%: ΔmgrB locus? No amplification with 1F/R 
• 3%: Insertion of ISKpn14 at nt 124 
• Δ18/27 (frameshift and premature termination) 
• a7t (nonsense, premature termination) 
• Δg47 (frameshift and premature termination) 
• Δ109/119 (frameshift and premature termination) 
• Insertion of IS1F-like at nt 105 
• ΔmgrB (from -400 to +599) 
• t71a (L24H) 
• g83a (C28Y) 
Transcriptional analysis (qPCR) 
Col-S 
All affect pmrHFIJKLM operon, 
thus LPS  
Lancet Infect. Dis. 2015 November 18  
IncI2 
Highly conjugative with E.  coli 
(frequency of 101-103 cells per recipient) 
mcr- 1  encodes for a  
Phosphoethanolamine transferase enzyme 
Use of antibiotics in Food Producing Animals - SWITZERLAND 
Hinchliffe P et al., Scientific Reports, Jan 2017 
MCR-1 catalyzes transfer of PEA onto 
glucosamine saccharide of lipid A in the OM 
Less net negative 
charge (COL-R) 
5 membrane α-helices 
Periplasmic domain Catalytic domain 
Zinc metalloprotein 
Phenotypic tests 
(e.g., MIC with EDTA) 
Food animals Food Humans 
Skov and Monnet - Eurosurv. March, 2016 
Most strains were 
3GC-R and stored!  
Eurosurveillance July, 2016 
IncX4 
35 Kbp 
53 colistin-R E. coli of porcine origin 
• mcr-1 in 7 (13%) 
• mcr-2 in 11 (21%) 
52 colistin-R E. coli of 52 bovine origin 
• mcr-2 in 1 (2%) 
mcr-1 (1’626 bp) – mcr-2 (1’617 bp): 77% nt identity 
MCR-1 and MCR-2 proteins show 81% identity 
Identical to one found in Salmonella enterica 
(but mcr-negative) 
 
Very high conjugation frequency (1.7 x 10-3) 
Moraxella spp. 
China, 2015 
380 colistin-R E. coli from pig feces 
• mcr-3 in 7 (1.8%) 
200 colistin-R E. coli from chicken cloacae 
• No mcr-3 
45% and 47% nt identity with mcr-1 and mcr-2, respectively 
33% and 32% aa identity with MCR-1 and MCR-2, respectively 
 
MCR-3 showed 94-95% aa identity to proteins found in Aeromonas spp. 
IncHI2 
261 Kbp 
Very similar backbone 
compared to IncHI2 
plasmids carrying mcr-1 
Eurosurv. Aug, 2017 
ColE10 
8,749 bp 
IS5 flanked region: 
99% identity with  
Shew. frigidimarina  
MCR-4 has 82-99% aa identity with phosphoethanolamine 
transferases found in Shewanella spp. 
Conjugation only in 
presence of IncI2 
plasmid (helper) 
125 E. coli from piglets with diarrhea 
• 50 were colistin-R 
• 32 with mcr-1; 3 with mcr-2; 11 with mcr-4  
Strain R4278 
Plasmid integrated into 
chromosome; flanked by 
IS5 
34%, 35% and 49% aa identity with  
MCR-1, MCR-2, and MCR-3, respectively 




Food chain Environment 
Wildlife Pets 
Companion Animals 
Hospitals Nursing homes 










One Health Concept: mcr genes 
Real-time PCR: 24.8% 
Culture-based: 15.9%  
only mcr-1 
32 E. coli, 2 K. pneumoniae 
We need further details on 
the production process 
(chain of production) 
Enterobacteriaceae from river (n=105) and 
sewage (n=90) around Barcelona (2013) 













28/29 (pulsotypes I, II, III) were ST1196 
Reported in carbapenemase producers  
from humans/dogs  
SYBRGreen-based real-time PCR 
 
Winter 2011 (Nov-Jan) vs. winter 2016 (Nov-Jan)  
P<0.05 
Evidence for the growing spread of mcr- 1  
E. coli: 13’526 strains 
• Colistin-R: n=59, 0.4%  
• of which mcr-1: n=19, 0.1%   
K. pneumoniae: 7’480 strains 
• Colistin-R: n=331, 4.4%  
• of which mcr-1: n=0, 0%   
Urine sample. Feb-March, 2016: 
2049 Enterobacteriaceae of which 1704 E. coli 
Only one E. coli mcr-1: prevalence 0.05% 
1144 stool samples. July-Oct, 2016: 
Colistin-R Enterobacteriaceae: prevalence 1.5-3.8% 
No mcr-1/-2 producers: prevalence 0.0% 
979 K. pneumoniae from 43 hospitals (2016): 
Only two mcr-1-positive: prevalence 0.2% 
Human infections/colonization 
with mcr-1-like producers 
44-y man hospitalized in Portugal 
VAP due to A. baumannii, P. aeruginosa, CP K. pneumoniae 
Successfully treated with colistin for 20 days 
After 2 months, ICU in France where  




E. coli WI2: contained two additional plasmids 
• IncX4, 33Kb: mcr- 1  
• IncL, 62Kb: blaOXA-48   
ST1288 
(identical) 
Wang Y et al., Lancet Infect Dis, Apr 2017 
Infections 
Colonization 
Sporadic cases (not screened before trip) 
Only 3GC-R strains tested for COL-R 
- Mulvey MR et al., LID, March 2016 
- Doumith M et al., JAC, April 2016 
- Arcilla MS et al., LID, Feb 2016 
What is the real prevalence of MCR-1 producers? 
ESBL/pAmpC/Carbapenemase 
producers with MCR-1 
MCR-1 producers 
(“Susceptible strains”) 
Plasmids carrying only mcr-1 (non-ESC-R) 
IncI2 








After 3 months 12 months 
TRIP 











Stools MALDI-TOF MS 
Before trip: 
- 3/38 (~8%) with CTX-Ms E. coli 
After trip: 
- 29/38 (~76%) with ESC-R-Enterobacteriaceae 
- 26/38 with CTX-Ms E. coli 
- 3/38 with DHA E. coli 
At 3 months: 
- 11/34 (~32%) with ESC-R-Enterobacteriaceae 
- 10/34 with CTX-Ms E. coli 
- 1/34 with CMY-2-like E. coli 
At 6 months: 
- 8/31 (~26%) with ESC-R-Enterobacteriaceae 
- 5/31 with CTX-Ms E. coli 
- 3/31 with cAmpC, CMY-2-like E. coli 
At 12 months: 
- 4/25 (~16%) with ESC-R-Enterobacteriaceae 
- All CTX-Ms 
All ESBL/pAmpC strains were:  
- polymyxins-S (MICs ≤1 mg/L) 
- PCR negative for mcr- 1  









PCR for mcr-1/2 
MICs Trek panels 





























strategy for  
COL-R strains 
Problem: species naturally R to COL 




Overall, no other species (only E.  coli) 
* 









Stools #2 Stools #3 Stools #4 Stools #5 






- 9 - 
E.  coli non-ESC-R 
B2-ST141 
COL MIC = 6 mg/L 
PCR mcr-1 = neg 
- - 
19 53 F ITA - 20 - - - 
E.  coli non-ESC-R 
A/B1-ST5 
COL MIC = 6 mg/L 
PCR mcr- 1  = POS 
26 50 F 
ITA  
FRA 
E.  coli non-ESC-R 
D1-ST69 
COL MIC = 4 mg/L 
PCR mcr-1 = neg 
14 - - - - 




- 9 - 
E. coli CTX-M 
New-ST 
COL MIC = 8 mg/L 
PCR mcr-1 = neg 
- - 





E. coli CTX-M 
D2-New-ST 
COL MIC = 12 mg/L 
PCR mcr-1 = neg 
Drop out  Drop out Drop out 





E. coli DHA 
B1-ST3075 
COL MIC = 6 mg/L 
PCR mcr-1 = neg 
- - Drop out 





E. coli CTX-M 
D1-New-ST 
COL MIC = 4 mg/L 
PCR mcr-1 = neg 
- - - 
100 57 F - - 14 
E.  coli non-ESC-R 
A1-ST10 
COL MIC = 12 mg/L 
PCR mcr- 1  = POS 
- - - 
COL-R 1/38 (2.6%) 
MCR-1 0/38 
COL-R 4/38 (10.5%) 
MCR-1 1/38 (2.6%) 
3 months 6 months 
New screening 
strategy for  
COL-R strains 
9 mcr- 1  E.  coli (3 humans; 6 meat) 
- 7 plasmid-mediated  
- 2 chromosomally located 
Prevalence of mcr-1 producers: 
- HIV+, 1% 
- Travelers, 5.2% 
- Chicken meat from Germany, 1.1% 




Most with ISApI1  





In blue from this study or Switzerland 
CMY-2-IncK2 plasmids 
represents a major attack in 
EU chicken production 
 
They are frequently carried by 
a hyperepidemic ST38 E.  coli 
clone transmitted to humans 
One chromosomal copy 
(in a ST38 E.  coli) 
Two chromosomal copies 
2,600 bp composite transposon (?) 
[Tn6330.2] 
Creation of two truncated forms 
No transposition events Transposition frequency (2.2 x 10-8) 
ISApl1 first identified in  
Actinobacillus pleuropneumoniae (Pasteurellaceae) 
Porcine necrotic pleuropneumonia 
Chew KL, JCM, Sep 2017 
Sensitivities for detecting mcr- 1-positive strains 
Performance in comparison to BMD 
Performance of simulated breakpoints 
CLSI, 2017: S ≤ 2 mg/L – R ≥ 2 mg/L (Ec, Kp, Ea, Ecl, Ro) 
EUCAST, 2017: S ≤ 2 mg/L – R > 2 mg/L 
Both recommend broth microdilution (BMD) 
Should we  
lower cutoff? 
76 Enterobacteriaceae  
(21 mcr-1) 
Not for disk! 
74 colistin-R Enterobacteriaceae  
(61 with mcr-1-like) 
Cation-adjusted MH broth 
(CLSI) 
A MIC reduction of at least 
8-fold dilution 
Jayol A. et al., J Clin Micro; 54:9, 2016 
Final results in 2-4 hrs 





Acid formation observed with pH indicator (phenol red) 
+ + 
Jayol A. et al. CMI, June 2017 
BMD, gold standard 
BD Phoenix automated system 
• 10 Very Major Errors (12%) 
Rapid Polymyxin NP test 
• 1 Very Major Error (1.2%) 
• 1 Major Error (1.2%) 
123 Enterobacteriaceae: 
83 were colistin-R 
Position of the ligation probes E. coli possessing  
mcr-1, blaCTX-M-1 and blaTEM-1 
E. coli possessing  
mcr-2 and blaTEM-1 
Highly accurate: both sens/spec: 100% 
50-85 Euro 
• Preparation (2-5 min) 
• No DNA extraction 
• Run time (<30 min) 
LAMP (Eazyplex SuperBug mcr- 1  kit) 
Loop-mediated isothermal Amplification 
Real-time fluorescent measurement 
Genie II platform 
~55 Euro 
104 Enterobacteriaceae: 
 - 67 mcr-1-positive 
 - 37 mcr-1-negative (including 9 colistin-R) 
 
Sensitivity and Specificity: both 100% 
TAT: < 20 minutes 
40 cycles with native stools 










E. coli 31349 
ST5 (IncX4) 
Traveler 
E. coli #100 
ST10 (IncHI2) 
Traveler 





34 cycles Negative 
100 mg stools eluted in 100 µL 
4 µL template; final reaction in 20 µL 
LOD: 10 copies / reaction 
30 cycles with the enrichment 
HIV+ 
E. coli 31349 
ST5 (IncX4) 
Traveler 
E. coli #100 
ST10 (IncHI2) 
Traveler 
E. coli #19 
ST5 (IncHI2) 
Positive 






The prevalence of COL-R Enterobacteriaceae is increasing 
- Human hospital setting – especially K. pneumoniae 
- Chromosomal (mostly mgrB) 
- Animal/food/environment settings – especially E. coli 
- Plasmid-mediated mcr-1-like based 
Use of colistin 
mcr- 1-like are spreading rapidly  
- Plasmids highly stable and able to conjugate 
- Transposition of the ISAbI1 transposon 
- Species carrying mcr-like genes  
Detection of COL-R strains (incl. mcr- 1-like) presents issues 
- BMD is not routinely implemented (Etest and disks not adequate) 
- Automated systems have problems (VMEs) 
- Not many molecular systems have been developed 
- Expensive 
- Most of them not for clinical samples 
They can establish themselves 
into hyperepidemic MDR clones 
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